Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Coronavirus: Dundee professor hails potential ‘game changer’ with Pfizer trial vaccine success

Professor James Chalmers.
Professor James Chalmers.

A Dundee professor has hailed the possibility of a coronavirus vaccine coming from Pfizer’s trials as a “massive moment in the pandemic”.

Professor James Chalmers, who has been heavily involved in the local response to Covid-19, also described the development as a “game changer”.

The trials have included tens of thousands of people and, with a reported 90% effective rate, sparked hope that a vaccine is within sight.

Professor Chalmers Tweeted: “If this is as good as advertised when the full data is released, this is a massive moment in the pandemic. Better than many expected and potentially the game changer we have been waiting for.”

He later added: “It’s a great day for science, with all the caveats of waiting for the full data, but amid all the congratulations to Pfizer I think we should take a moment to thank 43,500 amazing people that took an experimental vaccine to make this happen.”

Professor Chalmers, who is a consultant respiratory physician, has been directly working with coronavirus patients at Ninewells Hospital.

The professor, who lives in Perth, is also professor of respiratory research at Dundee University.

The potential vaccine being developed by Pfizer and BioNTech needs to be stored at -80C, which has raised some concerns for developing countries’ ability to rollout the drug.

Professor Chalmers did remark that this was “unfortunate” when asked about it on social media.

He has been careful not to raise hopes in the past over potential vaccines.

In July, he told the Sunday Post it was unlikely a vaccine would be ready and rolled out across Scotland by the end of the year when hopes of one emerged from trials in Oxford.